α-2-macroglobulin in saliva is associated with glycemic control in patients with type 2 diabetes mellitus.

Juan Pablo AitkenCarolina OrtizIrene Morales-BozoGonzalo Rojas-AlcayagaMauricio BaezaCaroll BeltranAlejandro Escobar

Published in: Disease markers (2015)

Our data strongly suggest that the level of saliva α-2-macroglobulin is an indicator for the degree of glycemic control in diabetic patients and represents a promising alternative method to evaluate this parameter.

Keyphrases

glycemic control
type diabetes
blood glucose
weight loss
insulin resistance
electronic health record
big data
skeletal muscle
blood pressure